HPV16 E6 variants: Frequency, association with HPV types and in silico analysis of the identified novel variants

Journal of Medical Virology

Volumn 86, Issue 6, 2014, Pages 968-974

  Gokhale, Priyanka S ^a   Sonawani, Archana ^a   Idicula Thomas, Susan ^a   Kerkar, Shilpa ^a   Tongaonkar, Hemant ^b,c   Mania Pramanik, Jayanti ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^b TATA MEMORIAL HOSPITAL   (India)

^c P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

E6 variants; HPV16; Molecular docking; Phylogenetic analysis

Indexed keywords

ADULT; AMERICAN INDIAN; ARTICLE; COMPUTER MODEL; FEMALE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 16 E16; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; MIDDLE AGED; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS; UTERINE CERVIX CANCER; WART VIRUS; AGED; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; COMPLICATION; DNA SEQUENCE; EPIDEMIOLOGY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MOLECULAR DOCKING; MOLECULAR EPIDEMIOLOGY; PAPILLOMAVIRUS INFECTIONS; PROTEIN CONFORMATION; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; VIRUS DNA;

ADULT; AGED; DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INDIA; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MOLECULAR EPIDEMIOLOGY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN CONFORMATION; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 84897958268     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23924     Document Type: Article

References (55)

1. Andersson S, Alemi M, Rylander E, Strand A, Larsson B, Sallstrom J, Wilander E. 2000. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplasticlesions. Br J Cancer 83:307-310.
2. Berumen J, Ordonez RM, Lazcano E, Salmeronj Galvan SC, Estrada RA, Yunes E, Gonzalez-Lira G, Madrigal-de la Campa A. 2001. Asian-american variants of human papillomavirus 16 and risk for cervical cancer: A case-control study. J Natl Cancer Inst 93:1325-1330.
3. Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, Sinnott P, Stern PL. 1998. HPV 16 infection and progression of cervical intra-epithelial neoplasia analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78:166-171.
4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A world wideperspective. International biological study on cervical cancer (IBSCC)Study group. J Natl Cancer Inst 87:796-802.
5. Chaturvedi AK, Brinkman JA, Gaffga AM, Dumestre J, Clark RA, Dunlap K, Kissinger PJ, Hagensee ME. 2004. Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J Gen Virol 85:1237-1241.
6. Chen R, Weng Z. 2003. ZDOCK: An initial-stage protein-docking algorithm. Proteins 52:80-87.
7. Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe V, Gravitt PE, Hsing AW, Burk RD. 2011. Evolution and taxonomic classification of human papillomavirus 16(HPV16) related variant genomes: HPV 31, HPV 33, HPV 35, HPV 52, HPV 58 and HPV 67. PLoS ONE 6:e20183.
8. Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM. IARC HPV variant study group. 2012. HPV 16 genetic variants: Phylogeny and classification based on E6 and LCR. J Virol 86:6855-6861.
9. Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, zur Hausen H, Luthra UK. 1992. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 36:239-245.
10. Da Costa MM, Hogeboom CJ, Holley EA, Palefsky JM. 2002. Increased risk of high-grade neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 185:1229-1237.
11. Del Refugio Gonzalez-Losa M, LaviadaMier Y, Teran MA, Puerto-Solís M, García-Carrancá A. 2004. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol 29:95-98.
12. Ellis JRM, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Young LS, Stern PL. 1995. The association of HPV16 oncogene variant with HLA-B7 has implications for vaccine design I cervical cancer. Nat Med 1:464-470.
13. Felsenstein J. 2005. PHYLIP (Phylogeny Inference Package) version 3.6.Distributed by the author. Seattle: Department of Genome Sciences, University of Washington.
14. Gheit T, Cornet I, Clifford GM, Iftner T, Munk C, Tommasino M, Kjaer SK. 2011. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population based sample of Danish women. Cancer Epidemiol Biomarkers Prev 20:1315-1321.
15. Grodzki M, Besson G, Clavel C, Arslan A, Franceshi S, Birembaut P, Tommasino M, Zehbe I. 2006. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 15:820-822.
16. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
17. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiologic studies and construction of a phylogenetic tree. J Clin Microbial 29:1765-1772.
18. Hu X, Pang T, Guo Z, Mazurenko N, Kisseljov F, Pnten J, Nister M. 2001. HPV 16 E6 gene variation in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br J Cancer 84:791-795.
19. Kast WM, Brandt RM, Sidney JW, Drjifhout RT, Kubo HM, Grey CJ, Melief CJ, Sette A. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol 152:3904-3912.
20. Kerkar SC, Latta S, Salvi V, Mania-Pramanik J. 2011. Human papillomavirus infection in asymptomatic population. Sex Reprod Healthc 2:7-11.
21. Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissmann L, Lowy DR, Schiller JT. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into vrus-like particles. J Virol 67:6929-6936.
22. Kolaskar AS, Tongaonkar PC. 1990. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172-174.
23. Li L, Chen R, Weng Z. 2003. RDOCK: Refinement of rigid-body protein docking predictions. Proteins 53:693-707.
24. Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L. 2006. HPV 16 E6 natural variants exhibit different activities in functional assays relevant tocarcinogenic potential of E6. Virology 350:216-227.
25. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69:364-368.
26. Matsumoto K, Yasugi T, Nakagawa S, Okubo M, Hirata R, Maeda H, Yoshikawa H, Taketani Y. 2003. Human papillomavirus 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 106:919-922.
27. Munoz N. 2000. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 19:1-5.
28. Myers G, Bernard HU, Delius H, Baker C, Icenogle J, Halpern A, Wheeler C. 1995. Human papillomaviruses. A compilation and analysis of nucleic acid and amino acid sequences. Publication LA-UR 95-3675. Los Alamos, NM: Los Alamos National Laboratory.
29. Nindl I, Rindfleisch K, Lotz B, Scheider A, Durst M. 1999. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82:203-207.
30. Page RD 1996. Tree View: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 12:357-358.
31. Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, Sharma R, Batra S, Das BC. 2008. Human papillomavirus type 16 variant analysis of E6, E7 and L1 genes and long control region in biopsy samples from cervical cancer patients in North India. J Clin Microbiol 46:1060-1066.
32. Picconi MA, Alonio LV, Sichero L, Mbayed V, Villa LL, Gronda J, Campos R, Teyssié A. 2003. Human papillomavirus type 16 variants in Quechua aboriginals from Argentina. J Med Virol 69:546-552.
33. Pierce B, Weng Z. 2007. ZRANK: Rerankingprotein docking predictions with an optimized energy function. Proteins 67:1078-1086.
34. Pillai MR, Sreevidya S, Pollock BH, Jayaprakash PG, Herman B. 2002. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol Oncol 87:268-273.
35. Pillai MR, Hariharan R, Babu JM, Lakshmi S, Chiplunkar SV, Patka M, Tongaonkar H, Dinshaw K, Jayshree RS, Reddy BKM, Siddiqui M, Roychoudury S, Saha B, Abraham P, Gnanamony M, Peedicayil A, Subhashini J, Ram TS, Dey B, Sharma C, Jain SK, Singh N. 2009. Molecular variants of HPV-16 associated with cervical cancer in Indian population. Int J Cancer 125:91-103.
36. Rastogi T, Hildesheim A, Sinha R. 2004. Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer 4:909-917.
37. Sathish N, Abraham P, Peedicayil A, Sridharan G, Chandi G. 2005. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. Cancer Lett 229:93-99.
38. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD. 2010. A population based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence and cervical neoplasia. Cancer Res 70:3159-3169.
39. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
40. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, Rao BN, Devi RR, Gravitt PE, Ramakrishna G. 2005. Prevalence and distribution of high-risk human papillomavirus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andra Pradesh, India. BMC Infect Dis 5:116-123.
41. Tornesello ML, Duratura ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De palo G, Franceschi S, Buonaguro FM. 2004. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 36:2046-2051.
42. Tsukui T, Hildesheim A, Schiffman MH, Lucci J, III. Contois D, Lawler P, Rush BB, Lorincz AT, Corrigan A, Burk RD, Qu W, Marshall MA, Mann D, Carrington M, Clerici M, Shearer GM, Carbone DP, Scott DR, Houghten RA, Berzofsky JA. 1996. Interleukin 2 production by peripheral lymphocyte in response to human papillomavirus-derived peptides: Correlation with cervical pathology. Cancer Res 56:3967-3974.
43. van Duin MP, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM. 2000. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81:317-325.
44. Veress G, Murvai M, Szarka K, Juhasz A, Konya J, Gergely L. 2001. Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. Eur J Cancer 37:1946-1952.
45. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968.
46. Volker A, Carlo M, Mirka S, Celestino R, Rita M, Jakob B. 1996. Detection and typing of human papillomavirus in biopsy and cytological specimen by polymerase chain reaction and restriction enzyme analysis: A method suitable for automation. J Med Virol 48:161-170.
47. Wheeler CM, Yamada T, Hidesheim A, Jenison SA. 1997. Human papillomavirus type 16 sequence variants: Identification by E6 and l1 lineage-specific hybridization. J Clin Microbial 35:11-19.
48. WHO/ICO. Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in India. Summary Report 2010 [3rd July 2013], Available at www.who.int/hpvcentre
49. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in united states populations characterized by nucleotide sequence analysis of the E6, L2 and L 1 coding segments. J Virol 69:7743-7753.
50. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: A world wide perspective. J Virol 71:2463-2472.
51. Zehbe I, Voglino G, Delius E, Wilander E, Tommasino M. 1998a. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.
52. Zehbe I, Wilander E, Delius H, Tommasino M. 1998b. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833.
53. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M. 2001. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94:711-716.
54. Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T. 2009. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in US population. Int J Cancer 125:2609-2613.
55. zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2:342-350.